PINK:SGPYY

The Sage Group Stock News

Technology > Software - Application

Buy SGPYY

*Your capital is at risk

$42.52

+0.0600 (+0.141%)

At Close: Jun 23, 2026

Sage Therapeutics Inc Under Investigation By The Schall Law Firm For Possible Securities Breaches Urging Investors With Losses To Start Conversation

03:15pm, Monday, 15'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Begins Investigation Into Sage Therapeutics Inc For Potential Securities Violations And Urges Investors With Losses To Initiate Conversation

07:00pm, Saturday, 13'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Inquiry Into Sage Therapeutics Inc For Possible Securities Breaches Initiated By The Schall Law Firm Encouraging Investors With Losses To Start Dialogue

06:45pm, Friday, 12'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Under Investigation By The Schall Law Firm For Possible Securities Breaches Urging Investors With Losses To Start Conversation

02:30pm, Thursday, 11'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Initiates Inquiry Into Sage Therapeutics Inc For Potential Securities Violations And Encourages Investors With Losses To Establish Dialogue

02:00pm, Wednesday, 10'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Starts Investigation Into Sage Therapeutics Inc For Possible Securities Breaches And Urges Investors With Losses To Set Up Communication

02:45pm, Tuesday, 09'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Initiates Probe Into Sage Therapeutics Inc For Potential Securities Violations And Encourages Investors With Losses To Establish Communication

01:45pm, Monday, 08'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Begins Investigation Into Sage Therapeutics Inc For Suspected Securities Breaches And Promotes Investors With Losses To Get In Touch

11:00am, Sunday, 07'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Is Conducting An Inquiry Into Sage Therapeutics Inc For Likely Securities Infringements And Invites Impacted Investors To Reach Out

11:00am, Saturday, 06'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Initiates Examination Into Sage Therapeutics Inc For Possible Securities Violations And Encourages Affected Investors To Establish Contact

04:00pm, Friday, 05'th Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Violations Of Securities Laws And Investors Who Incurred Losses Are Encouraged To Reach Out

03:15pm, Tuesday, 02'nd Jul 2024

LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,

The Schall Law Firm Is Probing Sage Therapeutics Inc For Possible Breaches Of Securities Regulations And Urges Investors Who Endured Losses To Reach Out

05:00pm, Wednesday, 26'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Being Probed By The Schall Law Firm For Potential Securities Law Violations And Investors With Losses Are Encouraged To Reach Out

03:00pm, Tuesday, 25'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Law Breaches And Investors With Losses Are Urged To Connect

04:30pm, Monday, 24'th Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

The Schall Law Firm Investigates Sage Therapeutics Inc For Potential Violations Of Securities Laws And Encourages Investors Who Have Suffered Losses To Get In Touch

11:00am, Sunday, 23'rd Jun 2024

LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by